Astragaloside IV mitigates mitochondrial damage and neurological symptoms in rats with cervical spondylotic myelopathy by inhibiting IL-17/TRAF6/NF-κB pathway.
Medicine
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.